Literature DB >> 18779317

p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.

Manabu Taura1, Ayaka Eguma, Mary Ann Suico, Tsuyoshi Shuto, Tomoaki Koga, Kensei Komatsu, Takefumi Komune, Takashi Sato, Hideyuki Saya, Jian-Dong Li, Hirofumi Kai.   

Abstract

Toll-like receptors (TLRs) are important sensors of microbial pathogens and mediators of innate immune responses. Although the signal transduction of TLRs is well elucidated, their basal regulation is largely unexplored. Here we show that the tumor suppressor p53 positively regulates the transcription of TLR3, a receptor for viral double-stranded RNA and poly(I-C), by binding to the p53 site in the TLR3 promoter. TLR3 expression was lower in HCT116 p53(-/-) cells than in HCT116 p53(+/+) cells. Activation of p53 by 5-fluorouracil increased the TLR3 mRNA in epithelial cell lines with wild-type p53 but not in cell lines harboring mutant p53. Knockdown of p53 by small interfering RNA decreased the TLR3 expression. TLR3 mRNA was also lower in liver and intestine of p53(-/-) mice than in p53(+/+) mice. Furthermore, the poly(I-C)-induced phosphorylation of IkappaB-alpha, nuclear translocation of NF-kappaB, and phosphorylation of interferon regulatory transcription factor 3, were drastically reduced in HCT116 p53(-/-) cells, indicating a dysregulation of the two signaling pathways governed by TLR3. Consequently, induction of interleukin-8 and beta interferon after poly(I-C) stimulation was impaired in HCT116 p53(-/-) cells. These results suggest that p53 influences TLR3 expression and function and highlight a role of p53 in innate immune response in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779317      PMCID: PMC2573237          DOI: 10.1128/MCB.01202-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products.

Authors:  S Djelloul; M E Forgue-Lafitte; B Hermelin; M Mareel; E Bruyneel; A Baldi; A Giordano; E Chastre; C Gespach
Journal:  FEBS Lett       Date:  1997-04-14       Impact factor: 4.124

2.  Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

Authors:  Elizabeth Furrie; Sandra Macfarlane; George Thomson; George T Macfarlane
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

3.  Enhanced proliferative potential in culture of cells from p53-deficient mice.

Authors:  T Tsukada; Y Tomooka; S Takai; Y Ueda; S Nishikawa; T Yagi; T Tokunaga; N Takeda; Y Suda; S Abe
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

4.  Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.

Authors:  Elizabeth Turpin; Kimberly Luke; Jeremy Jones; Terrence Tumpey; Kouacou Konan; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  p53-A pro-apoptotic signal transducer involved in AIDS.

Authors:  Maria Castedo; Jean-Luc Perfettini; Mauro Piacentini; Guido Kroemer
Journal:  Biochem Biophys Res Commun       Date:  2005-06-10       Impact factor: 3.575

6.  Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.

Authors:  T Tamura; N Aoyama; H Saya; H Haga; S Futami; M Miyamoto; T Koh; T Ariyasu; M Tachi; M Kasuga
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

7.  Down-regulation of p53 by double-stranded RNA modulates the antiviral response.

Authors:  Joao T Marques; Dominique Rebouillat; Chilakamarti V Ramana; Junko Murakami; Jason E Hill; Andrei Gudkov; Robert H Silverman; George R Stark; Bryan R G Williams
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  Evasion of intracellular host defence by hepatitis C virus.

Authors:  Michael Gale; Eileen M Foy
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

9.  Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein.

Authors:  Mary Ann Suico; Hiroki Yoshida; Yoshiyuki Seki; Tomoko Uchikawa; Zhuo Lu; Tsuyoshi Shuto; Kazuhito Matsuzaki; Mitsuyoshi Nakao; Jian-Dong Li; Hirofumi Kai
Journal:  J Biol Chem       Date:  2004-02-19       Impact factor: 5.157

10.  MEF up-regulates human beta-defensin 2 expression in epithelial cells.

Authors:  Zhuo Lu; Kyoung-Ah Kim; Mary Ann Suico; Tsuyoshi Shuto; Jian-Dong Li; Hirofumi Kai
Journal:  FEBS Lett       Date:  2004-03-12       Impact factor: 4.124

View more
  58 in total

1.  Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Authors:  Kenzo Ohara; Takayuki Ohkuri; Takumi Kumai; Toshihiro Nagato; Yui Nozaki; Kei Ishibashi; Akemi Kosaka; Marino Nagata; Shohei Harabuchi; Mizuho Ohara; Kensuke Oikawa; Naoko Aoki; Yasuaki Harabuchi; Esteban Celis; Hiroya Kobayashi
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

2.  Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1.

Authors:  Takashi Sugiyama; Tsuyoshi Shuto; Shingo Suzuki; Takashi Sato; Tomoaki Koga; Mary Ann Suico; Hiroyuki Kusuhara; Yuichi Sugiyama; Douglas M Cyr; Hirofumi Kai
Journal:  Biochem Biophys Res Commun       Date:  2010-12-22       Impact factor: 3.575

3.  Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells.

Authors:  Manabu Taura; Mary Ann Suico; Kosuke Koyama; Kensei Komatsu; Rui Miyakita; Chizuru Matsumoto; Eriko Kudo; Ryusho Kariya; Hiroki Goto; Shunsuke Kitajima; Chiaki Takahashi; Tsuyoshi Shuto; Mitsuyoshi Nakao; Seiji Okada; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2012-02-06       Impact factor: 4.272

4.  Gallid Herpesvirus 1 Initiates Apoptosis in Uninfected Cells through Paracrine Repression of p53.

Authors:  Hai Li; Qi Gao; Yuhao Shao; Bangyao Sun; Fengjie Wang; Yangyang Qiao; Nana Wang; Shengwang Liu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

5.  Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent.

Authors:  Joshua F Heiber; Glen N Barber
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

6.  Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53.

Authors:  Fayang Liu; Hongni Xue; Jie Ke; Yongyan Wu; Kezhen Yao; Shuxin Liang; Aihua Xu; Yong Zhang
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

8.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

Review 9.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 10.  Long story short: p53 mediates innate immunity.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Biochim Biophys Acta       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.